Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
about
In silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2LIL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsAssociation of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population.Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.DNA methylation modifications associated with chronic fatigue syndrome.Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune responseIL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance.Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL.The IL-33/ST2 pathway: therapeutic target and novel biomarker.The anti-atherogenic cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1, -4 and -5 in human macrophages: Requirement of extracellular signal-regulated kinase, c-Jun N-terminal kinase aAnti-parkinsonian effects of octacosanol in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-treated mice.Engagement of Fas on Macrophages Modulates Poly I:C induced cytokine production with specific enhancement of IP-10.A toll for T cell costimulation.New drugs targeting Th2 lymphocytes in asthma.Implications for Interleukin-33 in solid organ transplantationTLR2 is expressed on activated T cells as a costimulatory receptorNovel IL1RAPL1 mutations associated with intellectual disability impair synaptogenesis.Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.The biological and clinical importance of the 'new generation' cytokines in rheumatic diseasesLeukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.Quantitative phosphoproteomic analysis of IL-33-mediated signalingAssociation between IL-33 Gene Polymorphisms (rs1929992, rs7044343) and Systemic Lupus Erythematosus in a Chinese Han Population.Toll-like receptor 2 signalling and inflammation.Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.Modulating toll-like receptor-mediated inflammatory responses following exposure of whole cell and lipopolysaccharide component from Porphyromonas gingivalis in wistar rat models.The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells.
P2860
Q28476739-3629D6B6-B758-458E-ABCE-26CADF9B1E3EQ28513686-B6D8FDDB-31B0-401E-8B1D-BBAC795BBCA6Q33392397-8CFACA73-C83C-480D-817F-EBB320E66C7EQ33636556-18A46041-DDFD-4D47-9E64-B850BF33507DQ34027879-DDDA1643-F70E-41CD-A307-7D84D2058231Q34281893-B0501B73-552D-44B8-AB23-446315EAFB9FQ34289318-B3C9C27D-AA6B-427F-B27E-AC58581883C8Q34303629-C9FA829C-194A-48A8-9012-6F06771F5DC1Q34318269-0630FFC6-DD24-407B-A3D0-489FF0C0BA75Q34776884-CC5753BD-2B15-45F8-965A-CADE1958832DQ35052649-7BDD9877-1565-4AC3-852C-EC4F6CE3C422Q35120140-C4B8AFBC-BA42-44C0-8EE4-862309034BF2Q35596730-F4E0BE38-C379-4EB7-B49C-FFCF6BCC7E0AQ35915991-A74573C4-88D6-4A1E-8345-749B65516B41Q36485165-8ADA8F0E-7143-40D2-8C56-10EC8D7DEB58Q36807908-D1386053-98A0-46CF-9B3A-915DEF05C4C8Q36853515-A92EB372-6822-42F9-B29C-DDD095537CE5Q36901262-F092D219-5C61-48D8-8291-7C0EAB4A3A02Q37100750-41579C9A-DAD5-47A9-AE08-9331BD6E908FQ37516563-E65B25AF-5D92-4682-859C-4FD8B1BF896BQ37549767-3453F4CB-4030-45EF-9321-99A8470305F3Q38421390-FCE3E81B-7C20-4883-896E-646730B012A6Q40591524-15D30A10-950B-4DDB-A9E6-37FAB8CF7193Q42049824-0B0D3336-0ECB-4971-B541-9BBBF966821DQ45064301-F011A79C-F607-4D3D-86CD-B71BED0C6C31Q47100576-045F89AA-7977-44E9-801E-F4DC05B37F57Q48234431-72B00CDF-3B62-4668-9CDA-1F5321D53DB8
P2860
Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Characterization of signaling ...... inal kinase in IL-4 induction.
@ast
Characterization of signaling ...... inal kinase in IL-4 induction.
@en
Characterization of signaling pathways activated by the interleukin 1
@nl
type
label
Characterization of signaling ...... inal kinase in IL-4 induction.
@ast
Characterization of signaling ...... inal kinase in IL-4 induction.
@en
Characterization of signaling pathways activated by the interleukin 1
@nl
prefLabel
Characterization of signaling ...... inal kinase in IL-4 induction.
@ast
Characterization of signaling ...... inal kinase in IL-4 induction.
@en
Characterization of signaling pathways activated by the interleukin 1
@nl
P2093
P2860
P50
P356
P1476
Characterization of signaling ...... minal kinase in IL-4 induction
@en
P2093
Anthony J Coyle
Jose-Carlos Gutierrez-Ramos
Katherine A Fitzgerald
Philip Smith
P2860
P304
49205-49211
P356
10.1074/JBC.M209685200
P407
P577
2002-10-03T00:00:00Z